Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
PATH Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
House, draft bill 21st Cures Initiative, Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices. S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2015 · first_quarter · 1A
Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act. HR 09, the Innovation Act of 2014; STRONG Patents Act of 215.
Startup VISA Act; Invest VISA, Entrepreneurial VISA; Administration Action on Executive Order on Immigration.
Source: Senate LDA
House, draft bill 21st Cures Initiative, Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices. S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
American Entrepreneurship and Investment Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
American Entrepreneurship and Investment Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
American Entrepreneurship and Investment Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
American Entrepreneurship and Investment Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
American Entrepreneurship and Investment Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
Protecting Access to Medicare Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Protecting Access to Medicare Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Protecting Access to Medicare Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies for Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process.Requested Congress to have FDA review the SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics.
Protecting Access to Medicare Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Protecting Access to Medicare Act of 2014
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill#: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin. and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill#: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Patent Abuse Reduction Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Abuse Reduction Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Abuse Reduction Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Abuse Reduction Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 213; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Abuse Reduction Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
Patent Litigation Integrity Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Litigation Integrity Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 213; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Litigation Integrity Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
Patent Litigation Integrity Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Litigation Integrity Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Transparency and Improvements Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 213; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Transparency and Improvements Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Transparency and Improvements Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Transparency and Improvements Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
Patent Transparency and Improvements Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
StartUp Visa Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
StartUp Visa Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
StartUp Visa Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
StartUp Visa Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
StartUp Visa Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
Cybersecurity and American Cyber Competitiveness Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Cybersecurity and American Cyber Competitiveness Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Cybersecurity and American Cyber Competitiveness Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Cybersecurity and American Cyber Competitiveness Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Cybersecurity and American Cyber Competitiveness Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
Medical Device Access and Innovation Protection Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Medical Device Access and Innovation Protection Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Access and Innovation Protection Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Access and Innovation Protection Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Medical Device Access and Innovation Protection Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill#: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin. and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill#: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Patent Quality Improvement Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Quality Improvement Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Quality Improvement Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Patent Quality Improvement Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
Patent Quality Improvement Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 3309, the Innovation Act of 213; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Affordable Tutoring of Our Children Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
Affordable Tutoring of Our Children Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
Affordable Tutoring of Our Children Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
Affordable Tutoring of Our Children Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
Affordable Tutoring of Our Children Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013 Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft; Senate Finance tax discussion drafts.
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Medical Device Tax Elimination Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and information sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act(CISPA)
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
SECURE IT
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
End Anonymous Patents Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entities. Monitored issues. Have not taken a position on the legislation. HR 2024- End Anonymous Patents Act, enchanced disclosure of real party interests; S. 866 Patent Reality Improvement Act, expansion of CBM program; S1013: Patent Abuse Reduction Act, disclosure of real party interest.
End Anonymous Patents Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entities. Monitored issues. Have not taken a position on the legislation. HR 2024-End Anonymous Patents Act, enhanced disclosure of real party interests; S. 866 Patent Reality Improvement Act, expansio of CBM program; S1013: Patent Abuse Reduction Act, disclosure of real party interest.
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
SKILLS Visa Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Technology and Research Accelerating National Security and Future Economic Resiliency Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013 Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft; Senate Finance tax discussion drafts.
Protect Medical Innovation Act of 2013
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Cleantech an Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.
Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; Net Neutrality: Keep the internet free and open -- no "fast lanes".
Basic science research funding.
House, draft bill 21st Cures Initiative, Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices. S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.
Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2015 · first_quarter · Q1
Startup VISA Act; Invest VISA, Entrepreneurial VISA; Administration Action on Executive Order on Immigration.
Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act. HR 09, the Innovation Act of 2014; STRONG Patents Act of 215.
House, draft bill 21st Cures Initiative, Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a limited use pathway which can be used for a broad set of diseases and legislation that would create new pathways for the payment of medical devices. S.185 Promises for Antibiotics and Therapeutics for Health Act (PATH) Act, to create a limited population pathway for approval of certain antibacterial drugs.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, Senate Finance Committee Working groups, small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax.
Cleantech an Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.
Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; Net Neutrality: Keep the internet free and open -- no "fast lanes".
Basic science research funding.
Small company capital formation issues, implementation of Dodd-Frank, Implementation of JOBS Act, Tick Size Pilot.
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2014 · second_quarter · 2A
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy ad Water Appropriations. Senate Finance Energy Tax Paper.
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act.
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2014 · fourth_quarter · Q4
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.
HR 3309, the Innovation Act of 213; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill#: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin. and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill#: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act, Review of decimalization by the SEC, required under the JOBS Act. JOBS Act Roundtable.
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2014 · third_quarter · Q3
No bill#: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act, Review of decimalization study by the SEC, required under the JOBS Act. JOBS Act Roundtable.
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper; RFI on American Innovation.
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
S.232/HR 1295 Medical Device Access and Innovation Protection Act; would repeal the medical device tax as part of the ACA; S. Con. Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
HR 4178 American Entrepreneurship & Investment Act; S. 189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act. Administration Action on Executive Order on Immigration.
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2014 · second_quarter · 2A
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act.
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013: Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means tax reform discussion draft; Senate Finance tax discussion drafts; Chairman Dave Camp draft.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2014 · first_quarter · Q1
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2013 · fourth_quarter · 4A
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
HR 3309, S.1720, S.1612, S.1013, 5.806 -- various patent reform bills
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2013 · fourth_quarter · Q4
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile apps
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2013 · third_quarter · Q3
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entities. Monitored issues. Have not taken a position on the legislation. HR 2024-End Anonymous Patents Act, enhanced disclosure of real party interests; S. 866 Patent Reality Improvement Act, expansio of CBM program; S1013: Patent Abuse Reduction Act, disclosure of real party interest.
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expediate the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile Apps
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2013 · second_quarter · Q2
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expediate the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile Apps
Basic science research funding
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2013 · first_quarter · Q1
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
Cleantech and Energy Policy issues. New Energy Innovation tax issues; Budget issues for FY2013 Energy and Taxes; ARPA-E Funding.
No bill #. Lobbied Congress to work with the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway. That can be used for a broad set of discussions.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2012 · fourth_quarter · Q4
Cybersecurity Act of 2012 - S2105; Secure IT Act of 2012 - HR4263/S2151; Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and information sharing issues
Taxation of carried interest: capital gains tax policy; energy tax extenders; Energy Innovation Tax
Renewable energy policy issues: New Energy Innovation Tax issues; Continuing resolution: budget issues for FY2012 Energy and Taxes; ARPA-E Funding. Clean Energy Standard Act of 2012(CESA)
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2012 · third_quarter · Q3
Stop Online Piracy Act - HR 3261. Protect IP Act - S 968; Oppose SOPA and PIPA - oppose the Private Right of Action and the DNS provisions in the bills.
Renewable energy policy issues: Loan guarantee program and clean energy deployment administration budget issues for FY2012. Continuing resolution: budget issues for FY2012 Energy and Water; ARPA-E Funding. Clean Energy Standard Act of 2012 (CESA)
Cybersecurity Act of 2012 - S 2105; Secure IT Act of 2012 - HR 4263/S 2151; Bills to protect critical infrastructure against cyber based espionage and IP theft and terror attacks; Privacy and information sharing issues.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2012 · second_quarter · Q2
HR 3261 Stop Online Piracy Act; S968 Protect IP Act; Oppose SOPA and PIPA - oppose the Private Right of Action and the DNS provisions in the bills.
S 1700 The Medical Device Regulatory Improvement Act - support and clarify FDA's least burdensome rules.
Taxation of carried interest; capital gains tax policy; Energy tax extenders, Energy Innovation Tax
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2012 · first_quarter · Q1
Renewable energy policy issues: Loan guarantee program and clean energy deployment administration budget issues for FY2012. Continuing resolution: budget issues for FY2012 Energy and Water; ARPA-E funding. Clean Energy Standard Act of 2012(CESA)
S 2105Cybersecurity Act of 2012; HR 4263/S2151 - Secure IT Act of 2012; Bills to protect critical infrastructure against cyber based espionage and IP theft, and terror attacks. Privacy and information sharing issues
S17 Medical Device Access and Innovation Protection Act HR 436 Protect Medical Innovation Act of 2011 - lobbied to repeal the medical device tax act on small medical device companies
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2011 · fourth_quarter · Q4
S493 SBIR/STTR Reauthorization Act of 2011. Provisions that will allow venture capital companies to compete for SBIR/STTR grants and other SBA programs. HR 1425 Creating Jobs through Small Business Innovation Act.
Working with Congress on legislation that would provide reforms to the FDA regulatory process that would promote the advancement of medical innovation for both drugs and medical devices. HR 452/S 668 Health Care Bureaucratic Elimination Act-the Medical Decisions Accountability Act of 2011; lobbying to repeal the independent payment advisory board included in the Patient and Affordable Care Act. Advocating legislation for comprehensive FDA reform for drugs, biologics/medical devices.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2011 · third_quarter · Q3
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act(PL 111-203)
Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products. NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal
Renewable Energy Policy Issues: Loan Guarantee Program and Clean Energy Deployment Administration Budget issues for FY2012 Continuing resolution: Budget issues for FY2012 Energy and Water; ARPA-E Funding
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2011 · second_quarter · Q2
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203)
S23/HR1249 The America Invests Act of 2011. Lobbied on provisions dealing with post grant application procedures; first to file, PTO fee diversion and how these investments would impact small business investment and job growth.
Working with FDA's CDRH to establish a "special" predictable review process for novel technologies and ways to improve the 510(k) review process; HR 452 and S668 Health Care Bureaucratic Elimination Act - the Medicare Decisions Accountability Act of 2011; lobbying to repeal the independent payment advisory board included in the Patient Protection and Affordable Care Act. Advocation for legislation for comprehensive FDA reform for drugs, biologics and medical devices.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2011 · first_quarter · Q1
S 493 SBIR/STTR Reauthorization Act of 2011. Provisions that will allow venture capital companies to compete for SBIR/STTR grants and other SBA Programs. HR 1425 Creating Jobs Through Small Business Innovation Act.
Renewable Energy Policy Issues; Loan Guarantee Program and Clean Energy Deployment Administration Budget issues for FY2011 Continuing Resolution; ARPA-E Funding
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act(PL 111-203).
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2010 · fourth_quarter · Q4
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification. S1276 The Private Fund Transparency Act of 2009. NVCA wants language clarification to exclude the venture capital industry. HR 711 - The Hedge Fund Advisors Act of 2009; NVCA opposes any inclusion of venture capital industry in this bill. Title IV - Registration of Advisors to Private Fund: oppose administration language to require vc firms to register with the SEC.
HR2212 Clean Energy Development Administration - to improve the DOE Loan Guarantee and provide additional options for deploying energy technologies. S949-21st century deployment act-Energy Bank. HR1698 to establish the Green Bank to assist in the financing of qualified clean energy projects and energy efficiency projects. American Clean Energy Leadership Act: S3059-the Nat'l Energy Efficiency Enhancement Act to set new energy efficiency standards for products. S2857 to provide additional $2.5 billion in tax credits. S3813 to require utilities to obtain 15% of their power from renewable sources by 2021.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2010 · third_quarter · Q3
S.3793 The Tax Extenders Package, NVCA opposes the use of carried interest taxation as a revenue offest for these tax credits. HR4213 - The Unemployment Compensation Extension Act: NVCA opposes the use of carried interest tax changes as the revenue offset for this measure.
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital companies to compete for SBIR/STTR grants and other SBA Programs. HR2965: Enhancing small busines research and innovation act. S1233: a bill to reauthorize and improve SBIR/STTR programs for ther purposes.HR3738: Small Business Early Stage Investment Act of 2009: establishes a small business early stage investment program at the SBA. HR5297: The Small Business Lending Act of 2010, Title III, establishes a small business early-stage investment program at the SBA. NVCA supports this provision.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2010 · second_quarter · Q2
The American Recovery and Reinvestment Act - Making supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, state and local fiscal stablization for FY ending 9/30/09. Extend energy tax provisions 48(c) section 1603
S515 Patent Reform Act of 2009 - lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR1260 Patent Reform Act of 2009 - amend title 35; target tax relief for International Patents Act of 2010 (provided comments to the draft legislation) provides a small business tax credit for patent submissions.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2010 · first_quarter · Q1
HR4849 Small Business and Infrastructure Jobs Act of 2010; provisions on exclusion of small business capital gains;
Healthcare Reform-HR3590-The Patient Protection and Affordable Care Act; S1796: America's Healthy Future Act of 2009;S1679 Affordable Health Choices Act; support provisions to protect innovation with the overhaul of the healthcare system, specifically CER provisions, medical device and establishment of cures acceleration network.
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital backed companies to compete for SBIR/STTR grants and other SBA programs. HR2965: Enhancing small business research and innovation act. S1233: a bill to reauthorize and improve SBIR and STTR programs for other purposes. HR3738 Small Business Early Stage Investment Act of 2009: Allow venture capital backed companies to participate in SBIR/STTR grants and SBIR programs.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2009 · fourth_quarter · Q4
S515 Patent Reform Act of 2009 - lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 Patent Reform Act of 2009 - amend title 35
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital backed companies to compete for SBIR/STTR grants and other SBA programs. HR 2965: Enhancing small business research and innovation act: S1233: A bill to reauthorize and improve SBIR and STTR programs and for other purposes. HR3738: Small Business Early Stage Investment Act of 2009: Allow venture backed companies to participate in SBIR/STTR grants and SBIR programs
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2009 · third_quarter · Q3
HR 1935 to amend the IRS code of 1986 to provide for the treatment of partnership interests held by partners providing services. NVCA opposes change to the characterization of partnership interests for the venture capital industry.
Healthcare reform: support provisions to protect innovation with the overhaul of the healthcare system. NVCA supports America's Healthy Future Act of 2009(no bill #) specifically CER provisions and medical device.
S515 Patent Reform Act of 2009 lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 - Patent Reform Act of 2009 - amend title 35
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2009 · second_quarter · Q2
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital backed companies to compete for SBIR/STTR grants and other SBA Programs. HR2965 - Enhancing small business research and innovation act. S. 1233 - A bill to reauthorize and improve SBIR and STTR programs and for other purposes
S515 Patent Reform Act of 2009 - lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 - Patent Reform Act of 2009 - amend title 35
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2009 · first_quarter · Q1
The SBIR/STTR Reauthorization Act supported title II of the bill which would allow venture capital backed companies to compete for the SBIR/STTR grants and other SBA programs.
S515 Patent Reform Act of 2009 - lobbied on provisions dealing with post-grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 Patent Reform Act of 2009 - amend title 35
FDA Preemption - working with Congress to draft legislation that would establish a regulatory and reimbursement roadmap for medical diagnosis
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2008 · fourth_quarter · Q4
HR 5819 The SBIR/STTR Reauthorization Act supported title II of the bill which would allow venture capital backed companies to compete for SBIR/STTR grants and other SBA programs S 3362 The SBIR/STTR Reauthorization Act of 2008: against Section 108 which limited venture capital backed companies to only 18% of NIH SBIR funds and only 8% for other agencies.
S1145 The Patent Reform Act of 2007 - lobbied on provisions dealing with post-grant opposition procedures; damage apportionment and inequitable conduct.
HR 3161 FY08 FDA Appropriations: support increased funding for FDA. FY2009 Agriculture, Rural Development, FDA and Related Agencies- support increased FDA funding; currently there is not a bill # for 2009
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2008 · third_quarter · Q3
HR 5819 The SBIR/STTR Reauthorization Act: supported Title II of the bill which would allow venture capital backed companies to compete for SBIR grants and other SBA Programs S3362 The SBIR/STTR Reauthoization Act of 2008: against Section 108 which limited venture capital backed companies to only 18% of NIH SBIR funds and only 8% for all other agencies.
S1145 The Patent Reform Act of 2007 - lobbied on provisions dealing with post-grant opposition procedures; damage apportionment and inequitable conduct.
HR3161 FY08 FDA Appropriations: support increased funding for FDA. FY2009 Agriculture, Rural Development, FDA and Related Agencies - support increased FDA Funding; currently no bill # for 2009.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2008 · second_quarter · Q2
S1145 The Patent Reform Act of 2007 - lobbied on provisions dealing with post-grant opposition procedures; damage apportionment and inequitable conduct.
HR 5819 The SBIR/STTR Reauthorization Act; supported Title II of the bill which would allow venture capital backed companies to compete for SBIR grants and other SBA Programs
HR 3161 FY08 FDA Appropriations; support increased funding for FDA. FY2009 Agriculture, Rural Development, FDA and Related Agencies - support increased FDA funding - currently no bill number assigned for FY2009.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2008 · first_quarter · Q1
S. 1695 Biologic Price Competition and Innovation Act. Amends the Public Health Service Act(PHSA) to create an abbreviated biological product application for biologic products that are comparable, which NVCA opposes. HR 1956 Patient Protection and Innovative Biologics Medicine Act. Amends the PHSA to create an abbreviated biological production application for similar biological products. NVCA supports this bill. HR 5629 - The Pathway for Biosimilars Act, Amends the PHSA for similar biological products
Opposing efforts to use changes in partnership tax law as off-sets to anticipated AMT relief legislation(no bill number yet)
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2007 · year_end · YY
HR 3567: the Small Business Expansion Act of 2007, which would allow venture capital backed companies to compete for SBIR grants and other SBA programs; HR 1585 Section 1085 - Defense Reauthorization amendment to extend the SBIR program to 2010.
* FDA Reform User Fee Reauthorization S.1082 and HR 2900 to reauthorize the FDA user fees for prescription drugs and medical devices; to reform the FDA regulatory process. Biogenerics Pathway HR 1038 and S 623 - Access to Life Savings Medicine Act HR 1956, Patient Protection and Innovative Biologics Medicine Act; S.1695 Biologics Price Competition Act S.1859 and HR 3161 FY08 FDA Appropriations Biogenerics Pathway HR 1038 and S 623 - Access to Life Savings Medicine Act HR 1956, Patient Protection and Innovative Biologics Medicine Act; S.1695 Biologics Price Competition Act S.1859 and HR 3161 FY08 FDA Appropriations
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2007 · mid_year · RA
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2007 · year_end · RA
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2007 · mid_year · MM
HR 1908 The Patent Reform Act of 2007 S 1145 The Patent Reform Act of 2007
Comprehensive Immigration Reform Act 2007 S.9 S1397 Skilled Worker Immigration Act HR 1930 and S1083 - The Skill Act; Streamline VISA processing systems Increase HB1 cap to allow access to foreign talent and encourage US educated immigrants to remain the US;
HR 2337 Energy Policy Reform Act HR 364 Establishing the Advanced Research Projects Energy Agency(ARPA-E) Renewable energy, energy efficiency, encourage private sector investment
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2006 · year_end · YY
* American Competitiveness Act Improve K-12 Math and Science Education, improve teacher quality; Increase funding for basic research; Encourage students to pursue degrees in the STEM fields Retain the best and the brightest talent from around the world. HR 4434 10,000 Teachers, 10 million minds, Math and Science Scholarship Act HR 4596 Sowing the Seeds through Science and English Act Improve teacher quality in the K-12 education system.
S1263 and HR2943 SABIR Act - Allowing venture capital backed companies to compete for SBIR grants
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2006 · year_end · YY
No specific bills FDA Reform - Improving the pathway for novel technologies to receive FDA Approval
HR 810 and S 3504 and S2754 Stem Cell Research Enhancement Act - Permit the usage of stem cell technology to find cures for life threatening diseases
S1263 and HR2943 SABIR Act - Allowing venture capital backed companies to compete for SBIR grants
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2005 · year_end · YY
HR 2795 The Patent Reform Act of 2005
H-1B Visas, Immigration S2020 Tax Relief Act of 2005
HR 2942 adn S1263 Legislation that woudl permit small businesses that are majority owned by venture capital operating companies to participate in the SBIR grant program.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act).
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA); Net Neutrality: Keep the internet free and open -- no "fast lanes".
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem. Support the TROL Act, aimed at protecting businesses while preserving the ability of patent holders to legitimately protect their IP by increasing transparency with accountability in demand letters.
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies and Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process. Support language included in HR 4800, Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations Act of 2015 and in S. 2389, the FY2015 Senate Agriculture, Rural Development, Food & Drug Admin., and Related Agencies Appropriations highlighting the importance of the FDA SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics; No bill #: Lobbied Congress in support of the House E&C 21st Century Cures Initiative.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy ad Water Appropriations. Senate Finance Energy Tax Paper.
Filing targets: Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies for Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process.Requested Congress to have FDA review the SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics.
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations. Senate Finance Energy Tax Paper
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013 Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft; Senate Finance tax discussion drafts.
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile apps
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
HR 3309, S.1720, S.1612, S.1013, 5.806 -- various patent reform bills
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations. Senate Finance Energy Tax Paper
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entities. Monitored issues. Have not taken a position on the legislation. HR 2024- End Anonymous Patents Act, enchanced disclosure of real party interests; S. 866 Patent Reality Improvement Act, expansion of CBM program; S1013: Patent Abuse Reduction Act, disclosure of real party interest.
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations.
Taxation of carried interest: capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Taxation of carried interest: capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and information sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act(CISPA)
Shield Act of 2013, HR 845 - provide new limits to Patent Infringement lawsuits brought by non-practicing entitities. Monitored issues. Have not taken a position on the legislation.
Basic science research funding
Support for S.310, Startup Act 3.0, S.169 Immigration Innovation Act of 2013; S.189, Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Stop Online Piracy Act of 3261. Protect IP Act - S968; Oppose SOPA and PIPA - oppose the Private Right of Action and the DNS provisions in the bills
Medical Device Access and Innovation Protection Act - S.17 Protect Medical Innovation Act of 2011-HR436 - lobbied to repeal the medical device tax act on small medical device companies.
Support for EB6-The Start Up Visa Act allowing Foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country. HR3692/S3217 - Start Up Act - Allows STEM graduates to remain in the US. HR 3012 and HR 5893: Increase the family sponsored VISAS; eliminates the per country limit on VISAS.
Basic science research funding
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act(PL 111-203)
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Support for EB6 - The Start Up Visa Act allowing Foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country. HR 3692/S 3217 - Start Up Act - Allows STEM graduates to remain in the US. HR 3012 and HR5893 - Increase the per family sponsored VISAs; eliminates the per country limit on VISAs.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203)
Medical Device Access and Innovation Protection Act - S.17 Protect Medical Innovation Act of 2011 - HR 436 - lobbied to repeal the medical device tax act on small medical device companies
Startup Innovation Credit Act of 2012 -HR 6319/S 3460
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
S 1933/HR 3606 The Reopening American Capital Markets to Emerging Growth Companies Act of 2011: Support the entire bill
S 2105 Cybersecurity Act of 2012; HR 4263/S2151 - Secure IT Act of 2012; Bills to protect critical infrastructure against cyber based espionage and IP theft, and terror attacks; Privacy and information sharing issues.
Renewable energy policy issues: Loan guarantee program and clean energy deployment administration budget issues for FY2012. Continuing resolution: budget issues for FY2012 Energy and Water; ARPA-E Funding. Clean Energy Standard Act of 2012(CESA)
S.1734/HR2182 Gain Act - support incentives for antibiotic development; S2113 Treat Act; HR 4132 - FAST ACT - support expanding accelerated approval pathway
Specific lobbying issue: Support for EB6 - The Start Up Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country. HR 3692 Invest Act. S 3217 Start Up Act - Allows STEM graduates to remain in the US HR 3012 HR 5893 - Increase the per family sponsored VISAS; eliminates the per country limit on VISAS.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
S 1933/Hr 3606 The Reopening American Capital Markets to Emerging Growth Companies Act of 2011: Support the entire bill
Taxation of carried interest; capital gains tax policy
S1734/HR2182 Gain Act - support incentives for antibiotic development; S2113 Treat Act; HR 4132 - FAST Act - support expanding accelerated approval pathway
Specific lobbying issue: Support for EB6-The Start Up Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country; HR 3692 Invest Act
S23/HR1249 The America Invests Act of 2011. Lobbied on provisions dealing with post grant application procedures; first to file; and how these investments would impact small business investment and job growth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
HR3261 Stop Online Piracy Act; S968 Protect IP Act; Oppose SOPA and PIPA - oppose the "Private Right of Action" and the DNS provisions in the bills.
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act(PL 111-203)
Taxation of carried interest; capital gains tax policy
Specific lobbying issue: Support for EB6-The Start Up Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country.
Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products. NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal.
Renewable energy policy issues: Loan Guarantee Program and Clean Energy Deployment Administration Budget issues for FY 2012. Continuing resolution: Budget issues for FY2012 Energy and Water; ARPA-E funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
S493 SBIR/STTR Reauthorization Act of 2011. Provisions that will allow venture capital companies to compete for SBIR/STTR grants and other SBA programs. HR 1425 Creating Jobs through Small Business Innovation Act.
Working with Congress on legislation that would provide reforms to the FDA regulatory process that would promote the advancement of medical innovation for both drugs and medical devices. HR452/S668 Health Care Bureautic Elimination Act - the Medicare Decisions Accountability Act of 2011; lobbying to repeal the independent payment advisory board included in the Patient Protection and Affordable Care Act. Advocating legislation for comprehensive FDA reform for drugs, biologics/medical devices.
taxation of carried; capital gains tax policy
Specific lobbying issue: Support for EB6 - The StartUp Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country.
S23/HR1249 The America Invests Act of 2011. Lobbied on provisions dealing with post grant application procedures; first to file, PTO fee diversion and how these investments would impact small business investment and job growth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
S !7 Medical Device Access and Innovation Protection Act HR 436 Protect Medical Innovation Act of 2011 - lobbied to repeal the medical device tax on small medical device companies
Renewable Energy Policy Issues: Loan Guarantee Program and Clean Energy Deployment Administration Budget issues for FY 2011 Continuing resolution: Budget issues for FY2012 Energy and Water; ARPA-E Funding
S 493 SBIR/STTR Reauthorization Act of 2011. Provisions that will allow venture capital companies to compete for SBIR/STTR grants and other SBA programs. HR 1425 Creating Jobs through Small Business Innovation Act.
Taxation of carried interest
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
S23/HR1249 The America Invests Act of 2011. Lobbied on provisions dealing with post grant opposition procedures; first to file, PTO fee diversion and how these investments would impact small business investment and job growth.
Working with FDA's CDRH to establish a "special" predictable review process for novel technologies and ways to improve the 510(k) review process. Advocating for legislation for comprehensive FDA reform for drugs, biologics and medical devices
Taxation of carried interest
Personalized medicine: Working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products. NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office
S515 Patent Reform Act of 2009: lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR1260 Patent Reform Act of 2009 - amend Title 35; target tax relief for International Patents Act of 2010(provided comments to the draft legislation) provides a small business tax credit for patent submissions.
S325 Affordable Choices Act: PL111-48- America's Affordable Health Choices Act: Implementation of key provisions impacting medical innovation including Patient Centered Outcomes Research Institute(PCORI) and CMS Medicare Innovation Center; Funding for Cures Acceleration Network(CAN); Therapeutic Tax Credit.
HR 1935 to amend the IRC Code of 1986 to provide for the treatment of partnership interests held by partners providing services. NVCA opposes change to the characteritzation of partnership interests for the venture capital industry.
S.4053 SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital companies to compete for SBIR/STTR grants and other SBA Programs. HR 2965: Enhancing small business research and innovation act. S1233: a bill to reauthorize and improve SBIR/STTR programs for other purposes. HR3738: Small Business Early Stage Investment Act of 2009: establishes a small business early stage investment program at the SBA. HR5297: The Small Business Lending Act of 2010. Title 111 establishes a small business early stage investment program at the SBA. NVCA Supports this provision.
HR 1775(HR Res 105 and S Res 42) Making further continuing appropriations for FY2011.
Working with FDA's CDRH to establish a "special" predictable review process for novel technologies and ways to improve the 510(k) review process
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
S515 Patent Reform Act of 2009- lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 Patent Reform Act of 2009-amend title 35; target tax relief for International Patents Act of 2010 (provided comments to the draft legislation) provides a small business tax credit for patent submissions.
Working with FDA's CDRH to establish a "special" predictable review process for novel technologies and ways to improve the 510(k) review process
S325 Affordable Choices Act: PL111-48 - America's Affordable Health Choices Act: Implementation of key provisions impacting medical innovation including Patient Centered Outcomes Research Institute(PCORI) and CMS Medicare Innovation Center; Funding for Cures Acceleration Network(CAN); Therapeutic Tax Credit.
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification. S1276-The Private Fund Transparency Act of 2009. NVCA wants language clarification to exclude the venture capital industry. HR 711 - The Hedge Fund Advisor Act of 2009: NVCA opposes any inclusion of venture capital industry in this bill. Title IV - Registration of Advisors to Private Fund; oppose administration language to require vc firms to register with the SEC.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Healthcare Reform - HR3590 - The Patient Protection and Affordable Care Act; S1796: America's Healthy Future Act of 2009; S1679 Affordable Health Choices Act; support provisions to protect innovation with the overhaul of the healthcare system, specifically CER provisions, medical device and establishment of cures acceleration network.
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification. S.1276 - The Private Fund Transparency Act of 2009. NVCA wants language clarification to exclude the venture capital industry. HR 711 - The Hedge Fund Advisor Act of 2009; NVCA opposes any inclusion of venture capital industry in this bill. Title IV - Registration of Advisors to Private Fund, oppose administration language to require vc firms to register with the SEC.
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital companies to compete for SBIR/STTR grants and other SBA programs. HR 2965: Enchancing small business research and innovation act. S1233: a bill to reauthorize and improve SBIR/STTR programs for other purposes. HR3738 Small Business Early Stage Investment Act of 2009: establishes a small business early stage investment program at the SBA. HR 5297: The Small Business Lending Fund Act of 2010, Title III, establishes a small business early-stage investment program at the SBA. NVCA supports this provision.
FDA Preemption: S540 and HR1346 Medical Device Safety Act of 2009
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
S515 Patent Reform Act of 2009 - lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct. HR 1260 Patent Reform Act of 2009 - amend title 35; Target tax relief for International Patents Act of 2010(provided comments to the draft legislation) provides a small business tax credit for patent submissions.
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification. S.1276-The Private Fund Transparency Act of 2009. NVCA wants clarification language to exclude the venture capital industry. HR 711-The Hedge Fund Advisor Registration Act of 2009; NVCA opposes any inclusion of venture capital industry in this bill. Title IV - Registration of Advisors to Private Funds, oppose administration language to require vc firms to register with the SEC as investment advisors.
HR1 - American Recovery and Reinvestment Act S1213 - Patient Centered Outcomes Act of 2009; S1259 Patients Act of 2009; HR 1321 Healthy Americans Act; Expand CER, improve feedback to physicians, patient outcomes and protect innovation.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
HR 4213 - Amending the IRC to extend certain expiring provisions; NVCA opposes the use of changes to carried interest taxation as a revenue offset for these tax credits.
Healthcare reform: HR3590-The Patient Protection and Affordable Care Act; S1796: America's Healthy Future Act of 2009;S1679: Affordable Health Choices Act: support provisions to protect innovation with the overhaul of the healthcare system, specifically CER provisions, medical device and establishment of CURES acceleration network.
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification. S.1276 The Private Fund Transparency Act of 2009, NVCA wants clarification language to exclude the venture capital industry. HR 711- The Hedge Fund Advisor Registration Act of 2009; NVCA opposes any inclusion of venture capital industry in this bill. Title IV - Registration of Advisors to Private Funds, oppose administration language to require vc firms to register with the SEC as investment advisors.
HR1 - American Recovery and Reinvestment Act: S1213 - Patient Centered Outcomes Act of 2009; S1259 Patients Act of 2009; HR 1321 - Healthy Americans Act; Expand CER, improve feedback to physicians, patient outcomes and protect innovation.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Personalized medicine - working with Congress to establish a regulatory path for advanced diagnostic products.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Healthcare reform - support provisions to protect innovation with the overhaul of the healthcare system
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), White House Office
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA)
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA)
HR 6275 AMT Relief Act of 2008. Oppose provision to recharacterize income from investment services partnerships.
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Science Foundation (NSF), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA)
HR 5819 the SBIR/STIR Reauthorization Act which reauthorizes the SBIR program for two years and will clarify SBA's afflilation rules allowing majority venture-backed small business to participate in the program.
S1145 The Patent Reform Act of 2007. advocating for changes to the provisions around apportionment of damages, post grant opposition, inadequate conduct and venue.
Filing targets: Energy, Dept of, Financial Management Service (FMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Science Foundation (NSF), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office
* HR 2337 Energy Policy Reform Act HR 364 Establishing the Advanced Research Projects Energy Agency(ARPA-E): renewable energy; energy efficiency, encourage private sector investment; Increase the production of renewable fuels, increase energy efficiency and increase research in greenhouse gas. HR 6 Clean Energy Act of 2007: Energy Indepence and Security Act of 2007 HR 2641 Energy and Water Appropriation - funding for renewable energy HR 2419 Farm Security and Rural Investment Act - support provisions in the Farm bill to enhance renewable energy technologies, i.e biofuels, wind, solar. HR 6 Clean Energy Act of 2007: Energy Indepence and Security Act of 2007 HR 2641 Energy and Water Appropriation - funding for renewable energy HR 2419 Farm Security and Rural Investment Act - support provisions in the Farm bill to enhance renewable energy technologies, i.e biofuels, wind, solar.
* HR 362 - 10,000 teachers, 10 million minds, Math and Science Scholarship Act - sowing the seeds through Science and English Act Improve teacher quality in the k-12 education system HR 362 - 10,000 teachers, 10 million minds, Math and Science Scholarship Act - sowing the seeds through Science and English Act Improve teacher quality in the k-12 education system
Math and Science K-12 Education; STEM fields; increased funding for basic research and development, National Science Foundation and related agencies support for the office of technology policy.
HR 1908 Patent Reform Act of 2007 S 1145 The Patent Reform Act of 2007
Sarbanes Oxley Reform: Compete Act of 2007, S869, HR 1508 Section 404 Compliance Relief for Small Companies
* HR 2834, HR 4351 - AMT Relief Act of 2007; HR 3996 Tax Increase Prevention Act of 2007; HR3970 Tax Reduction and Reform Act of 2007: oppose provision to recharacterize income from investment services partnerships HR 4195, HR 4839 and S. 2374 - Tax Technical Corrections Act of 2007: to support revisions on Section 470 of the American Jobs Act. S.1624 Publicly traded partnership bill HR 4195, HR 4839 and S. 2374 - Tax Technical Corrections Act of 2007: to support revisions on Section 470 of the American Jobs Act. S.1624 Publicly traded partnership bill
Filing targets: Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Science Foundation (NSF), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
SBIR Grants; Patent Reform, Tax issues
HR 2834 to recharacterize income from "investment services partnerships" S. 1624: Publicly traded partnership bill
Sarbanes Oxley Reform: Compete Act of 2007, S869, HR 1508 Section 404 Compliance Relief for Small Companies
Allow venture capital backed companies to compete for SBIR grants
* FDA Reform User Fee Reauthorization S.1082 and HR 2900 to reauthorize the FDA user fees for prescription drugs nad medical devices; to reform the FDA regulatory process. Biogenerics Pathway HR 1038 and S 623 - Access to Life Savings Medicine Act HR 1956, Patient Protection and Innovative Biologics Medicine Act; S. 1695 Biologics Price Competition Act S.1859 and HR 3161 FY08 FDA Appropriations
Math and Science k-12 education; STEM Fields; Increased funding for basic research and development, National Science Foundation and related agencies support for the office of technology policy.
* HR 2272 and S761 America Competes Act Improve K-12 Math and Science Education, improve teacher quality HR 1867 National Science Foundation Act Increase funding for basic research; encourage students to pursue degrees in the STEM fields Retain the best and the brightest talent from around the world. HR 3043; HR 2669 College Cost Reduction Act HR 362 - 10,000 teachers, 10 million minds, Math and Science Scholarship Act Sowing the Seeds through Science and English Act Improve teacher quality in the K-12 education system
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office
No specific bills FDA Reform - Improving the pathway for novel technologies to receive FDA Approval
Comprehensive Immigration Reform Act of 2006 - S 2611 The Skill Act of 2006 HR 5744 and S 2691 Increase HB1 cap to allow access to foreign talent and encourage US educated immigrants to remain in the US. Streamline VISA processing systems
HR 2795 Patent Reform Act - Injunctive Relief S 3818 Patent Reform Act of 2006
HR 810 and S 3504 and S2754 Stem Cell Research Enhancement Act - Permit the usage of stem cell technology to find cures for life threatening diseases
Sarbanes Oxley Reform; HR5405 and S2824 Competitiveness Act Section 404 Compliance Relief For Small Companies
PACE Finance S 2199; PACE Energy S 2197; PACE S 2198; National Innovation Act S. 2109 and Hr 4654 Math and Science K-12 education; STEM fields. Increased funding for basic research and development, National Science Foundation and related agencies support for the Office of Technology Policy
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office
HR 2795 Patent Reform Act - Injunctive Relief S 3818 Patent Reform Act of 2006
PACE Finance S 2199; PACE Energy S 2197; PACE S 2198; National Innovation Act S. 2109 and Hr 4654 Math and Science K-12 education; STEM fields. Increased funding for basic research and development, National Science Foundation and related agencies support for the Office of Technology Policy
* American Competitiveness Act Improve K-12 Math and Science Education, improve teacher quality; Increase funding for basic research; Encourage students to pursue degrees in the STEM fields Retain the best and the brightest talent from around the world. HR 4434 10,000 Teachers, 10 million minds, Math and Science Scholarship Act HR 4596 Sowing the Seeds through Science and English Act Improve teacher quality in the K-12 education system.
Sarbanes Oxley Reform; HR5405 and S2824 Competitiveness Act Section 404 Compliance Relief For Small Companies
Comprehensive Immigration Reform Act of 2006 - S 2611 The Skill Act of 2006 HR 5744 and S 2691 Increase HB1 cap to allow access to foreign talent and encourage US educated immigrants to remain in the US. Streamline VISA processing systems
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office
PL 108-357 The American Jobs Creation Act Section 409A - Deferred Compensation Section 470 - Loss Limitation Provisions
HR 810 Stem Cell Research Enchancement Act S471 Stem Cell Research Enhancement Act of 2005
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA)